News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Biopharma Inc. (CBPC.OB) And HYTE Research LLC Enter Into Technology Partnership To Improve Safety And Efficacy Of Human Vaccines


11/29/2006 1:30:23 PM

PRINCETON, NJ -- (MARKET WIRE) -- November 28, 2006 -- China Biopharma, Inc. (OTCBB: CBPC), a biopharmaceutical company focused on developing and distributing human vaccine products in China, announced today that it has signed a letter of intent (LOI) with HYTE Research LLC, a New Jersey-based biotechnology research company. According to the agreement, the companies will jointly develop and commercialize Nano-Poly Enhancement technology for improving the effectiveness and reducing the side effects of human vaccines.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES